Epithelial basement membrane dystrophy (EBMD) is the most common type of corneal dystrophy, affecting 2% of the population. Although the majority of patients remain asymptomatic or experience minor episodic subjective discomfort, about 10% will eventually complain of recurrent erosions and/or visual disturbances.[1,2] The clinical course is often biphasic: Recurrent epithelial erosions predominate in the early phase, and visual disturbances occur in the later phase.
The pathophysiologic hallmark of EBMD is an abnormality in the formation and maintenance of the epithelial basement membrane adhesion complex of the corneal epithelium, a phenomenon that accounts for the recurrent erosions that are associated with this disorder. Originally described by Hansen over a century ago, and further characterized by Thygeson a half century later, recurrent erosions are acute disruptions of the corneal epithelium, which classically occur upon awakening and are associated with severe, sharp pain that may be transient or last for several hours or days, depending upon the surface area of epithelial sloughing. In severe cases, the erosion syndrome may be associated with considerable morbidity and occupational disability. Although erosions may occur in association with prior corneal trauma, EBMD is the most common cause of this disorder.
Initially, there may be few clinical signs associated with EBMD; however, a history of recurrent erosions should suggest this diagnosis, especially if they are bilateral and occur in multiple sites. With continued cycles of epithelial breakdown and aborted efforts at the development of a stable epithelial basement membrane adhesion complex, morphological changes eventually develop, which lead to the classic "map-dot-fingerprint" epithelial and subepithelial findings that characterize this disorder (Figures 1-3). Inadequate formation of hemidesmosomes by the basal epithelial cells results in compensatory aberrant regeneration and duplication of the epithelial basement membrane, a change that is clinically manifested by the "fingerprint" lines. The deposition of fibrogranular material below and above the abnormal basement membrane is responsible for the "map" and "dot" findings, respectively. When present in the visual axis, these epithelial and subepithelial irregularities initially result in irregular astigmatism and induction of higher order optical aberrations, which are subjectively associated with monocular diplopia and visual distortion—often before the development of a decrease in Snellen acuity. However, a progressive decline in Snellen acuity does occur as the morphological abnormalities increase in density, often in association with a paradoxical improvement in the erosion syndrome.
Successful treatment of EBMD is predicated upon optimizing conditions necessary for the formation of stable epithelial basement membrane adhesion complexes throughout the entire cornea, preferably before the development of vision-compromising morphological abnormalities in the visual axis. In most cases of EBMD, recurrent epithelial erosions can be prevented by the bedtime application of a lubricating or hyperosmotic ointment. If mild erosions frequently occur despite bedtime lubrication, the prolonged use of a bandage soft contact lens (SCL) may eliminate or greatly reduce the frequency of symptomatic erosions.
In the event that substantial epithelial erosions develop (Figure 4), more aggressive intervention is indicated. Successful management can be accomplished with manual superficial keratectomy (SK), followed by the reestablishment of an intact corneal epithelium that is firmly adherent and remains optically clear. Clinical and experimental evidence that has accumulated for more than a century regarding the development of the technique of manual SK and its application in this setting is summarized as follows:
In the present study, we reviewed the outcome of treating symptomatic EBMD with manual SK at University of Iowa Hospitals and Clinics (UIHC).
The medical records of every patient with EBMD who had been treated with manual SK by a member of the Cornea Service at UIHC from January 1, 1998, to December 31, 2007, were retrospectively reviewed. The diagnosis was established by a member of the cornea faculty on the basis of the characteristic clinical findings. Every eye had been treated with at least one mode of medical therapy before undergoing SK, including the use of topical lubrication, hyperosmotic agents, and/or bandage SCL therapy. The indications for surgical intervention were decreased vision and/or recurrent corneal epithelial erosions. Outcome measures included best spectacle-corrected visual acuity (BSCVA), the presence or absence of recurrent erosions, and symptomatic recurrent EBMD. Cases in which more than 3 months of postoperative follow-up were available were included in the statistical analysis. Eyes that had been previously treated with either manual SK or PTK prior to referral to UIHC or before the study period were excluded from the statistical analysis.
The surgical procedures were performed with topical anesthesia by members of the cornea faculty (KMG, JES, MDW) in the minor outpatient procedure room. The central corneal epithelium (6.0-8.0 mm) was debrided with a Weck cell sponge in most cases. Occasionally, a no. 57 Beaver blade was required to complete the epithelial removal. Poorly adherent epithelium in the periphery was also debrided when present. A no. 57 Beaver blade was also used to remove the basement membrane and subepithelial fibrosis with gentle scraping. Special precautions were taken to minimize the disturbance of the underlying Bowman's layer. The surface of Bowman's layer was then vigorously smoothed with a Weck cell sponge. In some cases early in the study period, a diamond burr was gently applied to the anterior surface of Bowman's layer. Later in the study period, stromal puncture was directly applied to Bowman's layer outside the visual axis where the epithelium had been debrided and through the epithelium in areas where it remained in place. One surgeon (MDW) applied light treatment in the visual axis in cases where erosions had been documented to occur in this zone or where substantial subepithelial fibrosis had been detected prior to the operative procedure. At the conclusion of the case, a bandage SCL was placed on the eye.
Postoperatively, all patients were treated with topical antibiotics and steroid drops 4 times daily for 1 week. Early in the study period, the bandage SCL therapy was discontinued in most cases after 1 week, the topical antibiotics and steroids were rapidly tapered and discontinued, and bedtime lubricating ointment was continued for at least 3 months. Later in the study period, the bandage SCL therapy was continued for 6 to 12 weeks in most cases, along with the administration of prophylactic topical antibiotics. In the latter half of the study, most patients were concomitantly treated with systemic doxycycline and topical corticosteroids until the bandage SCL therapy was completed.
Of 20 patients (14 men; 6 women), 22 eyes with EBMD were treated with manual SK for decreased vision (20 eyes) and/or recurrent epithelial erosions (15 eyes). The mean follow-up after surgery was 43.6 months (range, 3.0-115.2 months).
The treatment outcomes for decreased visual acuity are summarized in Table 1. Improvement was detected in BSCVA from a mean preoperative logMAR acuity of 0.313 (Snellen equivalent 20/41) to a best postoperative acuity of 0.038 (20/22) and a final acuity of 0.079 (20/24). A BSCVA of 20/20 or better was achieved in 12 (60.0%) eyes, and the same result was achieved at the most recent examination in 10 (50.0%) eyes. A BSCVA of 20/30 or better was achieved in 20 (100.0%) eyes, and the same result was achieved at the most recent examination in 19 (95.0%) eyes.
All 15 (100.0%) eyes with recurrent erosions had complete resolution of symptoms during the first 6 postoperative months. Between 6 and 60 months after initial treatment, 3 (20.0%) eyes experienced recurrent erosions. Among these, 2 eyes were successfully treated with a course of bandage SCL therapy, and 1 eye was successfully treated with excimer laser PTK.
No surgical complications resulted from any of the manual SK procedures.
|Best Spectacle-corrected Visual Acuity|
|Range||0.097 to 0.903||-0.125 to 0.176||-0.125 to 0.477|
|Range||20/25 to 20/160||20/15 to 20/30||20/15 to 20/60|
Our study strongly suggests that manual SK is a safe and effective treatment for visual disturbances and recurrent epithelial erosions associated with EBMD. No complications occurred in any of the 22 eyes treated with manual SK. Furthermore, all 20 eyes treated for visual disturbances experienced a sustained improvement in vision for the entire follow-up period. Although it would be intuitive to anticipate that the same morphological abnormalities would occur postoperatively in this genetic disorder, the establishment of stable epithelial basement membrane adhesion complexes and the reduction of recurrent epithelial erosions in the visual axis either completely prevents or substantially retards the recurrence of these changes and their adverse effects on visual function. Every patient experienced complete relief of recurrent erosion symptoms during the first 6 months, with only 3 experiencing symptoms in the subsequent decade. Among these, 2 cases were relatively minor and were managed with a 3-month course of bandage SCL therapy. One case was troublesome and required treatment of the entire basement membrane of the affected eye with excimer laser PTK.
Obtaining a lasting and satisfactory result with manual SK requires meticulous attention to the surgical technique, especially the thorough removal of all abnormal subepithelial pathology in the visual axis and the use of anterior stromal puncture, prolonged postoperative bandage SCL therapy, and appropriate pharmacological support. This technique is effective in providing a sustained improvement in the spectacle acuity of virtually every patient and relief from recurrent erosions in the vast majority of patients. It is preferred over broad area ablation with the excimer laser because it is much less expensive, is not associated with a hyperopic shift in the baseline refractive error, and is less likely to induce visually significant haze in the visual axis (Table 2).12,13 Nonetheless, it will occasionally be necessary to offer excimer laser PTK to the small percentage of patients in which manual SK is not completely successful in providing sustained relief from recurrent erosions, as was the case with 1 patient in the present series.
|Equipment||Simple surgical instruments are sufficient||Excimer laser required|
|Surgical Skill||Minimal training required||Certification course required|
|Postoperative morbidity||Pain may be present until epithelial defect resolves; minimal risk of corneal infection; virtually no risk of visually significant haze or scar formation||Pain may be present until epithelial defect resolves; minimal risk of corneal infection; significant haze or scar formation (especially if large refractive errors are treated)|
|Efficacy||Excellent prognosis for improved vision and resolution of recurrent epithelial erosions||Excellent prognosis for improved vision and resolution of recurrent epithelial erosions|
|Refractive Changes||Little or no change in spherical refractive error||Hyperopic shift may occur|
|Retreatment||Simple and inexpensive||Simple but expensive|
Excimer laser PTK may be offered in combination with photorefractive keratectomy (PRK) in primary therapy of EBMD if the therapeutic objective is to attain an improvement in uncorrected visual acuity. If this approach is adopted, the treating ophthalmologist must be cognizant of the potential that some of the measured refractive error may be factitiously induced by the epithelial and subepithelial morphological abnormalities associated with EBMD and that the refractive accuracy of PRK cannot be predicted with certainty. In such cases, a more conservative approach would be to perform a 2-stage procedure consisting of manual SK followed by PRK (after the refractive error has stabilized and can be measured accurately).
Pham LTL, Goins, KM, Sutphin JE, Wagoner MD. Treatment of Epithelial Basement Membrane Dystrophy With Manual Superficial Keratectomy. EyeRounds.org. Feb 22, 2010; Available from: http://www.eyerounds.org/cases/78-EBMD-treatment.htm.
Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa are licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.